Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
---|---|---|---|---|
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US8969412 | B BRAUN MEDICAL INC | Use for a composition comprising chloroprocaine HCL, a new composition comprising chloroprocaine HCL and a method for its manufacture |
Sep, 2026
(3 years from now) | |
US9504666 | B BRAUN MEDICAL INC | Chloroprocaine-based pharmaceutical composition for repeated intrathecal administration |
Dec, 2033
(10 years from now) |
Market Authorisation Date: 26 September, 2017
Treatment: A method for inducing a regional anaesthesia via intrathecal administration of a patented preservative free solution for injection (with a specific composition, ph, osmolality and density) containing 9-11 mg/ml chloroprocaine hcl
Dosage: SOLUTION;INTRATHECAL
Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
---|---|---|---|---|
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US10792271 | SINTETICA SA | Topical formulations of chloroprocaine and methods of using same |
Sep, 2038
(15 years from now) |
Market Authorisation Date: 27 September, 2022
Treatment: Method of inducing ocular anesthesia
Dosage: GEL;OPHTHALMIC
Click on the highlighted region to filter.
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic